CCR7 and neoplasm: CCL21, through binding to its receptor, chemokine (C-C motif) receptor 7 (CCR7), can attract dendritic cells (DCs), lymphocytes, natural killer (NK), and natural killer T (NKT) anti-tumor effectors to the tumor site.